The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6823
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats ; volume:11 ; number:1 ; day:26 ; month:5 ; year:2011 ; pages:1-13 ; date:12.2011
BMC endocrine disorders ; 11, Heft 1 (26.5.2011), 1-13, 12.2011
- Creator
-
Stunes, Astrid K.
- Contributor
-
Westbroek, Irene
Gustafsson, Björn I.
Fossmark, Reidar
Waarsing, Jan H.
Eriksen, Erik F.
Petzold, Christiane
Reseland, Janne E.
Syversen, Unni
SpringerLink (Online service)
- DOI
-
10.1186/1472-6823-11-11
- URN
-
urn:nbn:de:1111-2016071628824
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Stunes, Astrid K.
- Westbroek, Irene
- Gustafsson, Björn I.
- Fossmark, Reidar
- Waarsing, Jan H.
- Eriksen, Erik F.
- Petzold, Christiane
- Reseland, Janne E.
- Syversen, Unni
- SpringerLink (Online service)
Other Objects (12)
The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys
![In-vitro-Untersuchungen zur Beeinflussung des Proliferationverhaltens von Neuroblastomen durch PPAR-γ-Agonisten [PPAR-gamma-Agonisten]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
In-vitro-Untersuchungen zur Beeinflussung des Proliferationverhaltens von Neuroblastomen durch PPAR-γ-Agonisten [PPAR-gamma-Agonisten]
In-vitro-Untersuchungen zur Beeinflussung des Proliferationverhaltens von Neuroblastomen durch PPAR-γ-Agonisten [PPAR-gamma-Agonisten]
Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
Apoptosis rate and transcriptional response of pancreatic islets exposed to the PPAR gamma agonist Pioglitazone
Pioglitazone, a PPAR-y agonist, as one of the new therapeutic candidates for C3 glomerulopathy
The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function
Post-treatment with the PPAR-γ agonist pioglitazone inhibits inflammation and bacterial growth during Klebsiella pneumonia
Effekte von PPARγ-Agonisten [PPAR-Gamma-Agonisten] auf Proliferation und Differenzierung humaner Nebennierenrindenkarzinomzellen
Anwendung des PPARγ-Agonisten [PPAR-Gamma-Agonisten] Pioglitazon bei Patienten mit aktiver Psoriasisarthritis
Effekte von PPARδ-Agonisten [PPAR-delta-Agonisten] auf in-vitro-kultivierte humane Darmzellen
Vergleich der insulinsensitivierenden und lipidsenkenden Wirkung des PPAR-α-Agonisten [PPAR-alpha-Agonisten] BM 17.0744 mit Troglitazone (Rezulin) und Bezafibrat (Cedur)
The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys
In-vitro-Untersuchungen zur Beeinflussung des Proliferationverhaltens von Neuroblastomen durch PPAR-γ-Agonisten [PPAR-gamma-Agonisten]
In-vitro-Untersuchungen zur Beeinflussung des Proliferationverhaltens von Neuroblastomen durch PPAR-γ-Agonisten [PPAR-gamma-Agonisten]
Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
Apoptosis rate and transcriptional response of pancreatic islets exposed to the PPAR gamma agonist Pioglitazone
Pioglitazone, a PPAR-y agonist, as one of the new therapeutic candidates for C3 glomerulopathy
The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function
Post-treatment with the PPAR-γ agonist pioglitazone inhibits inflammation and bacterial growth during Klebsiella pneumonia
Effekte von PPARγ-Agonisten [PPAR-Gamma-Agonisten] auf Proliferation und Differenzierung humaner Nebennierenrindenkarzinomzellen
Anwendung des PPARγ-Agonisten [PPAR-Gamma-Agonisten] Pioglitazon bei Patienten mit aktiver Psoriasisarthritis
Effekte von PPARδ-Agonisten [PPAR-delta-Agonisten] auf in-vitro-kultivierte humane Darmzellen
Vergleich der insulinsensitivierenden und lipidsenkenden Wirkung des PPAR-α-Agonisten [PPAR-alpha-Agonisten] BM 17.0744 mit Troglitazone (Rezulin) und Bezafibrat (Cedur)
The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys
In-vitro-Untersuchungen zur Beeinflussung des Proliferationverhaltens von Neuroblastomen durch PPAR-γ-Agonisten [PPAR-gamma-Agonisten]
In-vitro-Untersuchungen zur Beeinflussung des Proliferationverhaltens von Neuroblastomen durch PPAR-γ-Agonisten [PPAR-gamma-Agonisten]
Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
Apoptosis rate and transcriptional response of pancreatic islets exposed to the PPAR gamma agonist Pioglitazone
Pioglitazone, a PPAR-y agonist, as one of the new therapeutic candidates for C3 glomerulopathy
The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function
Post-treatment with the PPAR-γ agonist pioglitazone inhibits inflammation and bacterial growth during Klebsiella pneumonia
Effekte von PPARγ-Agonisten [PPAR-Gamma-Agonisten] auf Proliferation und Differenzierung humaner Nebennierenrindenkarzinomzellen
Anwendung des PPARγ-Agonisten [PPAR-Gamma-Agonisten] Pioglitazon bei Patienten mit aktiver Psoriasisarthritis
Effekte von PPARδ-Agonisten [PPAR-delta-Agonisten] auf in-vitro-kultivierte humane Darmzellen